Milestone Scientific Surges Again
Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the […]
Milestone Scientific has a platform technology for the safe delivery of injections, with one application already commercialized and another one (the CompuFlo) close. The health and cost benefits of the […]
While the company is suffering from the pandemic and the economic fallout, it keeps on investing and can easily afford to do so. This is likely to lead to market […]
Duos Technologies has got a foothold in the rail industry where it is automating railcar inspections, and it is adding AI smarts to this process. The basic capabilities of the […]
The company has long been struggling to get growing again with a number of false dawns the past decade in a competitive industry. However, it looks like its focus on […]
The company is making steady progress in terms of market acceptance of its solutions, as well as in terms of financial performance. While there could very well be some headwinds […]
The company continues to build out its very valuable platform which aligns and simplifies a host of business processes for its customers. Demand for these “re-engineering” capabilities is likely to […]
Synacor is merging with Qumu in an all-stock deal, giving the combination more of a recurring SaaS nature. While the two businesses have been stagnant individually, there are some tentative […]
Usio is a payment processor that is close to being adjusted-EBITDA break-even, the only thing that needs to happen is scaling up further. There are legitimate concerns the pandemic could […]
The company’s shares plunged, as investors worry about cash flow and uncertainty about business conditions. While we share some of these concerns, a business update should at least allay some […]
The company had a stellar year with 48% revenue growth, margin expansion and a profit explosion. Some worries emerged about the company’s financial control mechanisms and the impact of COVID-19, […]